EP2501369A4 - Drug-loaded fibers - Google Patents
Drug-loaded fibersInfo
- Publication number
- EP2501369A4 EP2501369A4 EP10832096.1A EP10832096A EP2501369A4 EP 2501369 A4 EP2501369 A4 EP 2501369A4 EP 10832096 A EP10832096 A EP 10832096A EP 2501369 A4 EP2501369 A4 EP 2501369A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- drug
- loaded fibers
- fibers
- loaded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/620,334 US20100291182A1 (en) | 2009-01-21 | 2009-11-17 | Drug-Loaded Fibers |
PCT/US2010/057010 WO2011062974A1 (en) | 2009-11-17 | 2010-11-17 | Drug-loaded fibers |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2501369A1 EP2501369A1 (en) | 2012-09-26 |
EP2501369A4 true EP2501369A4 (en) | 2013-10-02 |
Family
ID=43431969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10832096.1A Withdrawn EP2501369A4 (en) | 2009-11-17 | 2010-11-17 | Drug-loaded fibers |
Country Status (7)
Country | Link |
---|---|
US (3) | US20100291182A1 (en) |
EP (1) | EP2501369A4 (en) |
JP (1) | JP2013511527A (en) |
AU (1) | AU2010322056B2 (en) |
CA (1) | CA2781108A1 (en) |
GB (2) | GB2475610B (en) |
WO (1) | WO2011062974A1 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100291182A1 (en) * | 2009-01-21 | 2010-11-18 | Arsenal Medical, Inc. | Drug-Loaded Fibers |
US8686060B2 (en) | 2009-08-03 | 2014-04-01 | Morgan Adhesives Company | Adhesive compositions for easy application and improved durability |
US9173817B2 (en) | 2009-08-24 | 2015-11-03 | Arsenal Medical, Inc. | In situ forming hemostatic foam implants |
US10420862B2 (en) | 2009-08-24 | 2019-09-24 | Aresenal AAA, LLC. | In-situ forming foams for treatment of aneurysms |
US9044580B2 (en) | 2009-08-24 | 2015-06-02 | Arsenal Medical, Inc. | In-situ forming foams with outer layer |
US20110202016A1 (en) * | 2009-08-24 | 2011-08-18 | Arsenal Medical, Inc. | Systems and methods relating to polymer foams |
MY168863A (en) | 2010-06-17 | 2018-12-04 | Univ Washington | Biomedical patches with aligned fibers |
US20120076972A1 (en) * | 2010-09-29 | 2012-03-29 | Hao Zhou | Nanofiber Non-Woven Composite |
US20120077405A1 (en) * | 2010-09-29 | 2012-03-29 | Hao Zhou | Core/Shell Nanofiber Non-Woven |
US8889572B2 (en) * | 2010-09-29 | 2014-11-18 | Milliken & Company | Gradient nanofiber non-woven |
US20120077406A1 (en) * | 2010-09-29 | 2012-03-29 | Scrivens Walter A | Nanofiber Non-Wovens Containing Particles |
US9861590B2 (en) * | 2010-10-19 | 2018-01-09 | Covidien Lp | Self-supporting films for delivery of therapeutic agents |
US9034240B2 (en) | 2011-01-31 | 2015-05-19 | Arsenal Medical, Inc. | Electrospinning process for fiber manufacture |
US8968626B2 (en) | 2011-01-31 | 2015-03-03 | Arsenal Medical, Inc. | Electrospinning process for manufacture of multi-layered structures |
US9194058B2 (en) | 2011-01-31 | 2015-11-24 | Arsenal Medical, Inc. | Electrospinning process for manufacture of multi-layered structures |
US8257641B1 (en) * | 2011-02-14 | 2012-09-04 | Xerox Corporation | Process of making core-sheath nanofibers by coaxial electrospinning |
WO2012114138A1 (en) * | 2011-02-21 | 2012-08-30 | Cerebel-Invest Sa | Biodegradable implants for the controlled subconjunctival release of an active molecule |
WO2013040325A1 (en) * | 2011-09-15 | 2013-03-21 | Arsenal Medical, Inc. | Implants for post-operative pain |
US8993831B2 (en) | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
BR112015006301B1 (en) | 2012-09-21 | 2021-06-15 | Washington University | SYSTEM TO PRODUCE A STRUCTURE THAT INCLUDES A PLURALITY OF FIBERS, STRUCTURE AND METHOD TO REPAIR A SUBSTRATE DEFECT |
US20140105956A1 (en) * | 2012-10-11 | 2014-04-17 | Rupak BANERJEE | Biodegradable polymer based microimplant for ocular drug delivery |
US8940684B2 (en) * | 2012-11-19 | 2015-01-27 | Mimedx Group, Inc. | Cross-linked collagen comprising an antifungal agent |
US8946163B2 (en) * | 2012-11-19 | 2015-02-03 | Mimedx Group, Inc. | Cross-linked collagen comprising metallic anticancer agents |
US9155799B2 (en) * | 2012-11-19 | 2015-10-13 | Mimedx Group, Inc. | Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent |
US9066853B2 (en) | 2013-01-15 | 2015-06-30 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable fiber |
US10029030B2 (en) | 2013-03-15 | 2018-07-24 | Mimedx Group, Inc. | Molded placental tissue compositions and methods of making and using the same |
US10335433B2 (en) | 2013-04-10 | 2019-07-02 | Mimedx Group, Inc. | NDGA polymers and metal complexes thereof |
US9446142B2 (en) | 2013-05-28 | 2016-09-20 | Mimedx Group, Inc. | Polymer chelator conjugates |
EP3038630B1 (en) | 2013-08-30 | 2020-03-18 | MIMEDX Group Inc. | Micronized placental compositions comprising a chelator |
JP6198548B2 (en) * | 2013-09-27 | 2017-09-20 | キヤノン株式会社 | Electrophotographic conductive member, process cartridge, and electrophotographic apparatus |
WO2015045365A1 (en) * | 2013-09-27 | 2015-04-02 | キヤノン株式会社 | Conductive roller and method for manufacturing same |
WO2015045402A1 (en) * | 2013-09-27 | 2015-04-02 | キヤノン株式会社 | Electrophotographic conductive member, process cartridge, and electrophotographic device |
JP6192466B2 (en) * | 2013-09-27 | 2017-09-06 | キヤノン株式会社 | Electrophotographic conductive member, process cartridge, and electrophotographic apparatus |
EP3188688B1 (en) * | 2014-09-06 | 2021-11-03 | Integral Biosystems LLC | Methods and biocompatible compositions to achieve sustained drug release in the eye |
US20180250224A1 (en) * | 2014-09-19 | 2018-09-06 | Oxular Limited | Ophthalmic Drug Compositions |
AU2015366355B2 (en) * | 2014-12-18 | 2020-05-28 | Dsm Ip Assets B.V. | Drug delivery system for delivery of acid sensitive drugs |
US20180200185A1 (en) | 2015-07-23 | 2018-07-19 | Novaflux, Inc | Implants and constructs including hollow fibers |
US10751293B2 (en) | 2015-09-03 | 2020-08-25 | Case Western Reserve University | Polymer fiber scaffolds and uses thereof |
WO2017083050A1 (en) | 2015-11-12 | 2017-05-18 | St. Teresa Medical, Inc. | A method of sealing a durotomy |
US10632228B2 (en) | 2016-05-12 | 2020-04-28 | Acera Surgical, Inc. | Tissue substitute materials and methods for tissue repair |
US20180221021A1 (en) * | 2017-02-08 | 2018-08-09 | Ethicon, Inc. | Braided suture with filament containing a medicant |
EP3641738A4 (en) * | 2017-06-20 | 2021-04-21 | St. Teresa Medical, Inc. | Hemostatic products |
EP3651746B1 (en) * | 2017-07-08 | 2023-09-13 | Hera Health Solutions Inc. | Bioerodible drug delivery implants |
US20190076632A1 (en) * | 2017-09-14 | 2019-03-14 | Amrita Vishwa Vidyapeetham | Suturable woven implants from electrospun yarns for sustained drug release in body cavities |
CN111712229A (en) | 2017-09-15 | 2020-09-25 | 奥叙拉尔有限公司 | Ophthalmic delivery device |
US10973775B2 (en) | 2017-09-22 | 2021-04-13 | University Of Manitoba | Antibacterial nanofiber |
WO2019089717A1 (en) | 2017-11-02 | 2019-05-09 | St. Teresa Medical, Inc. | Fibrin sealant products |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998053768A1 (en) * | 1997-05-30 | 1998-12-03 | Osteobiologics, Inc. | Fiber-reinforced, porous, biodegradable implant device |
WO2001032229A1 (en) * | 1999-11-04 | 2001-05-10 | Smith & Nephew Plc | Tissue repair |
US20050276841A1 (en) * | 2004-06-07 | 2005-12-15 | California Institute Of Technology | Biodegradable drug-polymer delivery system |
US20070232169A1 (en) * | 2006-03-31 | 2007-10-04 | Boston Scientific Scimed, Inc. | Medical devices containing multi-component fibers |
US20090196905A1 (en) * | 2008-02-06 | 2009-08-06 | Spada Lon T | Stabilization of mitochondrial membranes in ocular diseases and conditions |
Family Cites Families (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4764377A (en) * | 1983-10-07 | 1988-08-16 | The Forsyth Dental Infirmary For Children | Intra-pocket drug delivery devices for treatment of periodontal diseases |
US5567612A (en) * | 1986-11-20 | 1996-10-22 | Massachusetts Institute Of Technology | Genitourinary cell-matrix structure for implantation into a human and a method of making |
FI904598A0 (en) * | 1989-10-10 | 1990-09-18 | Wrigley W M Jun Co | GRADVIS AEMNESFRIGOERANDE STRUKTURER SOM FRAMSTAELLTS MED FIBERSPINNINGSTEKNIK. |
FI95537C (en) * | 1992-01-24 | 1996-02-26 | Biocon Oy | Surgical implant |
US5358677A (en) * | 1992-03-17 | 1994-10-25 | United States Surgical Corporation | Methods of forming bioabsorbable objects from polyvinyl alcohol |
GB9206509D0 (en) * | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges containing active agents |
NL9200625A (en) * | 1992-04-03 | 1993-11-01 | Dsm Nv | NON-WOVEN POLYOLEFINE FIBER LAYER FOR USE IN A LAYERED ANTIBALLISTIC STRUCTURE. |
US5922340A (en) * | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
US5538735A (en) * | 1993-02-19 | 1996-07-23 | Ahn; Sam S. | Method of making a drug delivery system using hollow fibers |
CA2212165A1 (en) * | 1995-02-10 | 1996-08-15 | Matthew A. Bergan | Method and device for administering analgesics |
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US6861570B1 (en) * | 1997-09-22 | 2005-03-01 | A. Bart Flick | Multilayer conductive appliance having wound healing and analgesic properties |
US5702720A (en) * | 1995-12-22 | 1997-12-30 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of flurbiprofen |
US5842477A (en) * | 1996-02-21 | 1998-12-01 | Advanced Tissue Sciences, Inc. | Method for repairing cartilage |
US5944341A (en) * | 1996-05-31 | 1999-08-31 | Nissan Motor Co., Ltd. | Air bag apparatus for vehicle |
JP2001519787A (en) * | 1997-04-03 | 2001-10-23 | ポイント バイオメディカル コーポレイション | Intravesical drug delivery system |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US20020164374A1 (en) * | 1997-10-29 | 2002-11-07 | John Jackson | Polymeric systems for drug delivery and uses thereof |
AU2705600A (en) * | 1998-10-01 | 2000-05-01 | University Of Akron, The | Process and apparatus for the production of nanofibers |
US6712610B2 (en) * | 1999-04-02 | 2004-03-30 | Forsyth Dental Infirmary For Children | Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy and method |
AU5852400A (en) * | 1999-07-28 | 2001-02-13 | Kaken Pharmaceutical Co., Ltd. | Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating the drug effect of antimicrobial agent, and antimicrobial agents |
US7033603B2 (en) * | 1999-08-06 | 2006-04-25 | Board Of Regents The University Of Texas | Drug releasing biodegradable fiber for delivery of therapeutics |
US6596296B1 (en) * | 1999-08-06 | 2003-07-22 | Board Of Regents, The University Of Texas System | Drug releasing biodegradable fiber implant |
CA2321321A1 (en) * | 1999-09-30 | 2001-03-30 | Isotis B.V. | Polymers loaded with bioactive agents |
US6737447B1 (en) * | 1999-10-08 | 2004-05-18 | The University Of Akron | Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof |
US6753454B1 (en) * | 1999-10-08 | 2004-06-22 | The University Of Akron | Electrospun fibers and an apparatus therefor |
WO2001054667A1 (en) * | 2000-01-28 | 2001-08-02 | Smithkline Beecham Corporation | Electrospun pharmaceutical compositions |
US6716449B2 (en) * | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
US6495124B1 (en) * | 2000-02-14 | 2002-12-17 | Macrochem Corporation | Antifungal nail lacquer and method using same |
US7074392B1 (en) * | 2000-03-27 | 2006-07-11 | Taro Pharmaceutical Industries Limited | Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections |
US20050033163A1 (en) * | 2001-04-24 | 2005-02-10 | Impres Medical, Inc. | Intrauterine implant and methods of use |
JP2002080348A (en) * | 2000-08-31 | 2002-03-19 | Nitto Denko Corp | Preparation for applying into oral cavity |
DE60114229T2 (en) * | 2000-11-29 | 2006-07-06 | Allergan, Inc., Irvine | PREVENTING TRANSPLANT DISCHARGE IN THE EYE |
US20040030377A1 (en) * | 2001-10-19 | 2004-02-12 | Alexander Dubson | Medicated polymer-coated stent assembly |
US6676953B2 (en) * | 2001-01-26 | 2004-01-13 | Don L. Hexamer | Antifungal composition and method for human nails |
JP3924672B2 (en) * | 2001-01-30 | 2007-06-06 | 株式会社ケーヒン | Vapor separator in outboard motor |
US20020176893A1 (en) * | 2001-02-02 | 2002-11-28 | Wironen John F. | Compositions, implants, methods, and kits for closure of lumen openings, repair of ruptured tissue, and for bulking of tissue |
US20030118630A1 (en) * | 2001-12-07 | 2003-06-26 | Anthony Cerami | Immune modulation device for use in animals |
US6685956B2 (en) * | 2001-05-16 | 2004-02-03 | The Research Foundation At State University Of New York | Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications |
US6821479B1 (en) * | 2001-06-12 | 2004-11-23 | The University Of Akron | Preservation of biological materials using fiber-forming techniques |
US6913760B2 (en) * | 2001-08-06 | 2005-07-05 | New England Medical Hospitals, Inc. | Drug delivery composition |
US6520425B1 (en) * | 2001-08-21 | 2003-02-18 | The University Of Akron | Process and apparatus for the production of nanofibers |
US20040137066A1 (en) * | 2001-11-26 | 2004-07-15 | Swaminathan Jayaraman | Rationally designed therapeutic intravascular implant coating |
US6790455B2 (en) * | 2001-09-14 | 2004-09-14 | The Research Foundation At State University Of New York | Cell delivery system comprising a fibrous matrix and cells |
TWI233811B (en) * | 2001-09-25 | 2005-06-11 | Ind Tech Res Inst | Sustained release micro-porous hollow fiber and method of manufacturing the same |
AU2002341959A1 (en) * | 2001-10-04 | 2003-04-14 | Case Western Reserve University | Drug delivery devices and methods |
US7309498B2 (en) * | 2001-10-10 | 2007-12-18 | Belenkaya Bronislava G | Biodegradable absorbents and methods of preparation |
WO2003047503A2 (en) * | 2001-10-22 | 2003-06-12 | University Of Mississippi | Delivery of medicaments to the nail |
US6695992B2 (en) * | 2002-01-22 | 2004-02-24 | The University Of Akron | Process and apparatus for the production of nanofibers |
US7198794B1 (en) * | 2002-02-22 | 2007-04-03 | Lorri Riley | Topical formulation for treating fingernails and toenails |
BRPI0309022A2 (en) * | 2002-04-04 | 2016-11-08 | Univ Akron | nonwoven fiber sets |
US20030195611A1 (en) * | 2002-04-11 | 2003-10-16 | Greenhalgh Skott E. | Covering and method using electrospinning of very small fibers |
US20050187605A1 (en) * | 2002-04-11 | 2005-08-25 | Greenhalgh Skott E. | Electrospun skin capable of controlling drug release rates and method |
US6861142B1 (en) * | 2002-06-06 | 2005-03-01 | Hills, Inc. | Controlling the dissolution of dissolvable polymer components in plural component fibers |
US20030017208A1 (en) * | 2002-07-19 | 2003-01-23 | Francis Ignatious | Electrospun pharmaceutical compositions |
US7824699B2 (en) * | 2002-07-22 | 2010-11-02 | Biodynamics Llc | Implantable prosthetic devices containing timed release therapeutic agents |
TW200410714A (en) * | 2002-08-07 | 2004-07-01 | Smithkline Beecham Corp | Electrospun amorphous pharmaceutical compositions |
US7029495B2 (en) * | 2002-08-28 | 2006-04-18 | Scimed Life Systems, Inc. | Medical devices and methods of making the same |
US7135194B2 (en) * | 2002-09-27 | 2006-11-14 | Birnbaum Jay E | Subunguicide, and method for treating onychomycosis |
GB0223870D0 (en) * | 2002-10-14 | 2002-11-20 | Cathnet Science Holding As | Stent assembly |
US20050043585A1 (en) * | 2003-01-03 | 2005-02-24 | Arindam Datta | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
NZ542501A (en) * | 2003-02-24 | 2009-09-25 | Marinepolymer Tech Inc | Compositions comprising chitin or chitosan and use thereof |
US7462362B2 (en) * | 2003-03-21 | 2008-12-09 | Nexmed Holdings, Inc. | Antifungal nail coat and method of use |
CN101193623A (en) * | 2003-05-15 | 2008-06-04 | 柏尔迈瑞克斯公司 | Reticulated elastomeric matrices manufacture and use |
US8226715B2 (en) * | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
US7235295B2 (en) * | 2003-09-10 | 2007-06-26 | Laurencin Cato T | Polymeric nanofibers for tissue engineering and drug delivery |
US8257614B2 (en) * | 2003-11-04 | 2012-09-04 | Sipix Imaging, Inc. | Electrophoretic dispersions |
WO2005081655A2 (en) * | 2004-02-17 | 2005-09-09 | The Children's Hospital Of Philadelphia | Gene and cell delivery self expanding polymer stents |
US20070190108A1 (en) * | 2004-05-17 | 2007-08-16 | Arindam Datta | High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair |
WO2006002366A2 (en) * | 2004-06-24 | 2006-01-05 | Surmodics, Inc. | Biodegradable ocular devices, methods and systems |
EP1627941A1 (en) * | 2004-08-17 | 2006-02-22 | Mosaic Systems B.V. | Functional porous multilayer fibre and its preparation |
US20060153815A1 (en) * | 2004-12-21 | 2006-07-13 | Agnieszka Seyda | Tissue engineering devices for the repair and regeneration of tissue |
US7575707B2 (en) * | 2005-03-29 | 2009-08-18 | University Of Washington | Electrospinning of fine hollow fibers |
DE602006019413D1 (en) * | 2005-05-03 | 2011-02-17 | Univ Akron | METHOD AND DEVICE FOR PRODUCING ELECTRO-SPANNED FIBERS AND FIBERS MADE THEREFOR |
GB0522569D0 (en) * | 2005-11-04 | 2005-12-14 | Univ Bath | Biocompatible drug delivery device |
US20070155273A1 (en) * | 2005-12-16 | 2007-07-05 | Cornell Research Foundation, Inc. | Non-woven fabric for biomedical application based on poly(ester-amide)s |
EP2004246B1 (en) * | 2006-04-11 | 2012-09-12 | Tyco Healthcare Group LP | Wound dressings with anti-microbial and zinc-containing agents |
US7485111B1 (en) * | 2006-06-05 | 2009-02-03 | Eugene Choi | Medicated sleeve |
US8936794B2 (en) * | 2006-08-25 | 2015-01-20 | The Regents Of The University Of Michigan | Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules |
US20080281350A1 (en) * | 2006-12-13 | 2008-11-13 | Biomerix Corporation | Aneurysm Occlusion Devices |
US8974814B2 (en) * | 2007-11-12 | 2015-03-10 | California Institute Of Technology | Layered drug delivery polymer monofilament fibers |
JP5541846B2 (en) * | 2008-04-22 | 2014-07-09 | 帝人株式会社 | Cotton-like structure for cardiovascular treatment and method for producing the same |
DE102008002641A1 (en) * | 2008-06-25 | 2009-12-31 | Biotronik Vi Patent Ag | Fiber strand and implantable support body with a fiber strand |
US20100291182A1 (en) * | 2009-01-21 | 2010-11-18 | Arsenal Medical, Inc. | Drug-Loaded Fibers |
WO2010088699A2 (en) * | 2009-02-02 | 2010-08-05 | Biomerix Corporation | Composite mesh devices and methods for soft tissue repair |
-
2009
- 2009-11-17 US US12/620,334 patent/US20100291182A1/en not_active Abandoned
-
2010
- 2010-11-17 WO PCT/US2010/057010 patent/WO2011062974A1/en active Application Filing
- 2010-11-17 GB GB1019445.4A patent/GB2475610B/en not_active Expired - Fee Related
- 2010-11-17 JP JP2012539996A patent/JP2013511527A/en active Pending
- 2010-11-17 EP EP10832096.1A patent/EP2501369A4/en not_active Withdrawn
- 2010-11-17 GB GB1401004.5A patent/GB2507677A/en not_active Withdrawn
- 2010-11-17 CA CA2781108A patent/CA2781108A1/en not_active Abandoned
- 2010-11-17 AU AU2010322056A patent/AU2010322056B2/en not_active Ceased
-
2012
- 2012-08-10 US US13/571,545 patent/US20120299223A1/en not_active Abandoned
-
2014
- 2014-02-05 US US14/173,099 patent/US20140199364A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998053768A1 (en) * | 1997-05-30 | 1998-12-03 | Osteobiologics, Inc. | Fiber-reinforced, porous, biodegradable implant device |
WO2001032229A1 (en) * | 1999-11-04 | 2001-05-10 | Smith & Nephew Plc | Tissue repair |
US20050276841A1 (en) * | 2004-06-07 | 2005-12-15 | California Institute Of Technology | Biodegradable drug-polymer delivery system |
US20070232169A1 (en) * | 2006-03-31 | 2007-10-04 | Boston Scientific Scimed, Inc. | Medical devices containing multi-component fibers |
US20090196905A1 (en) * | 2008-02-06 | 2009-08-06 | Spada Lon T | Stabilization of mitochondrial membranes in ocular diseases and conditions |
Non-Patent Citations (1)
Title |
---|
See also references of WO2011062974A1 * |
Also Published As
Publication number | Publication date |
---|---|
GB2507677A (en) | 2014-05-07 |
GB2475610B (en) | 2014-05-07 |
EP2501369A1 (en) | 2012-09-26 |
US20100291182A1 (en) | 2010-11-18 |
GB201401004D0 (en) | 2014-03-05 |
AU2010322056B2 (en) | 2016-02-18 |
US20120299223A1 (en) | 2012-11-29 |
CA2781108A1 (en) | 2011-05-26 |
WO2011062974A1 (en) | 2011-05-26 |
GB201019445D0 (en) | 2010-12-29 |
US20140199364A1 (en) | 2014-07-17 |
JP2013511527A (en) | 2013-04-04 |
AU2010322056A1 (en) | 2012-06-07 |
GB2475610A (en) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2475610B (en) | Drug-loaded fibers | |
DK3023438T3 (en) | Anti-gitr-antistoffer | |
DK2457337T3 (en) | Specialtilpasset impuls-burst | |
GB0905575D0 (en) | Electrospinning nozzle | |
IL218930A0 (en) | Expression system | |
EP2441869A4 (en) | Water-disintegrable fiber sheet | |
EP2462514A4 (en) | Greenbooks | |
EP2443235A4 (en) | ß-GLUCOSIDASE VARIANTS | |
EP2515891A4 (en) | 3-keto-n-propargyl-1-aminoindan | |
EP2503066A4 (en) | Construction machine | |
PL2486104T3 (en) | Textile structure | |
EP2652182A4 (en) | Controlled degradation fibers | |
EP2519921A4 (en) | Call-tracking | |
DK2464943T3 (en) | Systemintegration | |
ZA201107947B (en) | High elongation fibres | |
GB0900191D0 (en) | Microscopy | |
EP2652181A4 (en) | Degradable fibers | |
GB0916889D0 (en) | Splice variants | |
EP2510125A4 (en) | Hyperprimers | |
GB0907331D0 (en) | Modified batural fibres | |
AU4240P (en) | Tuckerbox xTriticosecale | |
AU4926P (en) | Bonscalib Scaevola aemula | |
AU4925P (en) | Bonscawi Scaevola aemula | |
AU4924P (en) | Bonscablue Scaevola aemula | |
GB201206482D0 (en) | #magnotherapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120517 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20130829 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/4468 20060101ALI20130823BHEP Ipc: A61K 31/575 20060101ALI20130823BHEP Ipc: A61K 31/485 20060101ALI20130823BHEP Ipc: A61K 31/4535 20060101ALI20130823BHEP Ipc: A61K 31/445 20060101ALI20130823BHEP Ipc: A61K 47/34 20060101ALI20130823BHEP Ipc: A61K 9/70 20060101AFI20130823BHEP Ipc: A61K 9/00 20060101ALI20130823BHEP |
|
17Q | First examination report despatched |
Effective date: 20150623 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20171013 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20180224 |